Showing results (391-400 of 887) with videos related to

Sort By:
Pageof 89
Circulation Research|June 12, 2014
Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editingQiurong Ding, Alanna Strong, Kevin M Patel, et al.
JCI Insight|August 20, 2024
Protein-truncating variant in APOL3 increases chronic kidney disease risk in epistasis with APOL1 risk allelesDavid Y Zhang, Michael G Levin, Jeffrey T Duda, et al.
Menopause (New York, N.Y.)|May 14, 2024
High-density lipoprotein metrics during midlife and future subclinical atherosclerosis in women: the SWAN HDL studyAlexis Nasr, Maria M Brooks, Emma Barinas-Mitchell, et al.
Human Molecular Genetics|April 1, 2026
Leveraging academic medical biobanks for recall-by-genotype deep phenotyping studiesYi-An Ko, Giselle Fisher, Eleonora Scorletti, et al.
Plos One|August 26, 2020
Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran programMarina Serper, Marijana Vujkovic, David E Kaplan, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2021
Associations of Endogenous Hormones With HDL Novel Metrics Across the Menopause Transition: The SWAN HDL StudySamar R El Khoudary, Alexis Nasr, Jeffrey Billheimer, et al.
Circulation Research|May 1, 2004
Endothelial lipase promotes the catabolism of ApoB-containing lipoproteinsUli C Broedl, Cyrille Maugeais, John S Millar, et al.
The New England Journal of Medicine|April 9, 2004
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterolMargaret E Brousseau, Ernst J Schaefer, Megan L Wolfe, et al.
Biological Psychiatry|September 13, 2020
Polygenic Risk of Psychiatric Disorders Exhibits Cross-trait Associations in Electronic Health Record Data From European Ancestry IndividualsRachel L Kember, Alison K Merikangas, Shefali S Verma, et al.
American Heart Journal|December 3, 2014
Reducing the burden of disease and death from familial hypercholesterolemia: a call to actionJoshua W Knowles, Emily C O'Brien, Karen Greendale, et al.
Pageof 89